Cerenome is trading at $1.64, up 5.10%, with no clear company-specific catalyst identified for the October 6 move.
- The latest listed company news is an investor presentation dated October 2, not an October 6 announcement.
- The Nasdaq Composite was up 0.52% and the S&P 500 was up 0.46%, providing a supportive market backdrop; available evidence does not establish these gains as the cause of Cerenomeβs move.